62
Participants
Start Date
October 11, 2017
Primary Completion Date
October 15, 2018
Study Completion Date
October 15, 2018
GSK2982772 capsule
GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.
Placebo capsule
Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.
GSK Investigational Site, Cambridge
Lead Sponsor
GlaxoSmithKline
INDUSTRY